首页> 外国专利> Use Of At Least One Effector Of Glutathione Metabolism Together With Alpha-Lipoic Acid For The Treatment Of Chronically Obstructive Lung Diseases

Use Of At Least One Effector Of Glutathione Metabolism Together With Alpha-Lipoic Acid For The Treatment Of Chronically Obstructive Lung Diseases

机译：谷胱甘肽代谢与α-硫辛酸的至少一种效应物在治疗慢性阻塞性肺疾病中的应用

页面导航

摘要
著录项
相似文献

摘要

The present invention relates to the use of at least one effector of glutathione metabolism together with α-lipoic acid, its salts and/or its pro-drugs for the simultaneous, separate or timed cytoprotective treatment of chronically obstructive lung diseases.

机译：本发明涉及谷胱甘肽代谢的至少一种效应物与α-硫辛酸，其盐和/或其前药一起用于慢性阻塞性肺疾病的同时，分开或定时的细胞保护性治疗的用途。

著录项

公开/公告号US2007212339A1

专利类型
公开/公告日2007-09-13

原文格式PDF
申请/专利权人 SIEGFRIED ANSORGE;DIETER KOEGST;MICHAEL TAEGER;GERHARD FRIES;
展开▼

申请/专利号US20040584072
发明设计人 SIEGFRIED ANSORGE;DIETER KOEGST;MICHAEL TAEGER;GERHARD FRIES;
展开▼

申请日2004-12-23
分类号A61K38/16;A61K31/385;
国家 US
入库时间 2022-08-21 21:06:45

相似文献

专利
外文文献
中文文献